Abrdn Healthcare Investors (HQH) Stock Price & Analysis
Abrdn Healthcare Investors (HQH) closed at USD 20.27 on Friday, October 23, 2026, down 0.69% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 20.27; the Oct 23, 2026 session ranged USD 20.09–20.43 on volume of 135,369 shares. Market capitalization is —, with a 52-week range of USD 17.14–24.85 (NYQ). Source: Nexqual, retrieved October 24, 2026 at 08:30 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HQH.md
Key facts (HQH)
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $5K; 1 not under a Rule 10b5-1 plan ($5K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $11K; 0 by opportunistic insiders, 0 by routine insiders.
- Total return with dividends: 1Y +20.4% vs S&P 500 +13.4%; 5Y +34.6% vs S&P 500 +76.9%.
Insider sales (SEC Form 4, open-market, last ~7 months) (HQH)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | Goodson Alan R | Director | 242 | $5K | 100% | No | Too little history (no open-market trades in 2024 or 2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (HQH)
1 purchase, $11K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-07-16 | Mahai Chris Lavictoire | Director | 501 | $11K | 20.96 | Too little history (no open-market trades in 2023–2025) |
Total return (dividends reinvested) (HQH)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +20.4% | +34.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +20.5% | +6.1% |
| Volatility (annualized) | 22.6% | 21.7% |
| Max drawdown | -20.9% (Aug 2026→Oct 2026) | -34.5% (Oct 2021→Oct 2023) |
Key Statistics (as of October 24, 2026 at 08:30 UTC)
| Price | USD 20.27 |
|---|---|
| Change | ▼ 0.69% (down) |
| Previous Close | USD 20.27 |
| Open | USD 20.27 |
| Day Range | USD 20.09 – 20.43 |
| 52-Week Range | USD 17.14 – 24.85 |
| Volume | 135,369 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (HQH)
Nexqual's technical model rates HQH "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 24, 2026 at 08:30 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.96 (neutral) |
| vs SMA50 | Below (USD 21.49) |
| MACD | -0.37 (negative) |
Earnings (HQH)
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Financials & Fundamentals (HQH)
| Total Revenue | $5.54M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -42.10% |
| Gross Margin | +100.00% |
| Operating Margin | -125.50% |
| Profit Margin | +4561.32% |
| ROE | +24.21% |
| Current Ratio | 1.03 |
| Total Debt | $0 |
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Ownership (HQH)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +23.66% |
Source: Nexqual, October 24, 2026 at 08:30 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HQL | Abrdn Life Sciences Investors | USD 17.73 | ▼ 1.23% |
| THW | Tekla World Healthcare Fund Sha | USD 12.49 | ▼ 2.04% |
| THQ | Tekla Healthcare Opportunies Fu | USD 18.38 | ▼ 2.23% |
| RVT | Royce Value Trust, Inc. | USD 16.45 | ▼ 1.2% |
| UTF | Cohen & Steers Infrastructure Fund, Inc | USD 26.11 | ▲ 0.12% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 08:30 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt